Douglas Roblin to Cost-Benefit Analysis
This is a "connection" page, showing publications Douglas Roblin has written about Cost-Benefit Analysis.
Connection Strength
0.051
-
Improving efficiency and reducing costs: Design of an adaptive, seamless, and enriched pragmatic efficacy trial of an online asthma management program. Contemp Clin Trials. 2014 May; 38(1):19-27.
Score: 0.028
-
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med. 2012 Feb 21; 156(4):263-70.
Score: 0.023